The host immune response to tuberculosis

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 3 PART I, 1998, Pages 679-691

  Schluger, Neil W ^a,b   Rom, William N ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CYTOKINE PRODUCTION; GRANULOMA; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; MACROPHAGE FUNCTION; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; T LYMPHOCYTE; TUBERCULOSIS;

EID: 0031947794     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.3.9708002     Document Type: Article

References (47)

1. Raviglione, M. C., D. E. Snider, Jr., and A. Kochi. 1995. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic (see comments). J.A.M.A. 273:220-226.
2. Young, L. S. 1993. Mycobacterial diseases and the compromised host. Clin. Infect. Dis. 17(Suppl. 2):S436-S441.
3. Weisner, D. 1922. Sanitorium follow-up studies. Am. Rev. Tuberc. 6:320-326.
4. Mitchell, R. 1955. Mortality and relapse of uncomplicated advanced pulmonary tuberculosis before chemotherapy: 1,504 consecutive admissions followed for fifteen to twenty-five years. Am. Rev. Tuberc. 72:487-512.
5. Stephens, M. 1941. Follow-up of 1,041 tuberculosis patients. Am. Rev. Tuberc. 44:451-462.
6. Turett, G. S., E. E. Telzak, L. V. Torian, S. Blum, D. Alland, I. Weisfuse, and B. A. Fazal. 1995. Improved outcomes for patients with multidrug-resistant tuberculosis. Clin. Infect. Dis. 21:1238-1244.
7. Park, M. M., A. L. Davis, N. W. Schluger, H. Cohen, and W. N. Rom. 1996. Outcome of MDR-TB patients, 1983-1993: prolonged survival with appropriate therapy. Am. J. Respir. Crit. Care Med. 153:317-324.
8. Colditz, G. A., T. F. Brewer, C. S. Berkey, M. E. Wilson, E. Burdick, H. V. Fineberg, and F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature (see comments). J.A.M.A. 271:698-702.
9. Stead, W. W. 1995. Management of health care workers after inadvertent exposure to tuberculosis: a guide for the use of preventive therapy. Ann. Intern. Med. 122:906-912.
10. Stead, W. W., J. P. Lofgren, E. Warren, and C. Thomas. 1985. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N. Engl. J. Med. 312:1483-1487.
11. Small, P. M., R. W. Shafer, P. C. Hopewell, S. P. Singh, M. J. Murphy, E. Desmond, M. F. Sierra, and G. K. Schoolnik. 1993. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N. Engl. J. Med. 328:1137-1144.
12. Das, S., C. N. Paramasivan, D. B. Lowrie, R. Prabhakar, and P. R. Narayanan. 1995. IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, South India. Tuber. Lung Dis. 76:550-554.
13. Lemaitre, N., W. Sougakoff, C. Truffot, J. Grosset, and V. Jarlier. 1996. Analysis of restriction fragment length polymorphism (RFLP) of Mycobacterium tuberculosis strains isolated from patients with several episodes of tuberculosis. Pathol. Biol. (Paris) 44:452-455.
14. Riley, R. L., C. C. Mills, W. Nyka, N. Weinstock, P. B. Storey, L. U. Sultan, M. C. Riley, and W. F. Wells. 1995. Aerial dissemination of pulmonary tuberculosis: a two-year study of contagion in a tuberculosis ward, 1959. Am. J. Epidemiol. 142:3-14.
15. Wells, W. 1955. Airborne Contagion and Air Hygiene. Harvard University Press, Cambridge, MA.
16. McDonough, K. A., and Y. Kress. 1995. Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of Mycobacterium tuberculosis. Infect. Immun. 63:4802-4811.
17. Diamond, G., M. Zasloff, H. Eck, M. Brasseur, W. L. Maloy, and C. L. Bevins. 1991. Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc. Natl. Acad. Sci. U.S.A. 88:3952-3956.
18. Dannenberg, A. M., Jr. 1994. Roles of cytotoxic delayed-type hypersensitivity and macrophage-activating cell-mediated immunity in the pathogenesis of tuberculosis. Immunobiology 191:461-473.
19. Israel, H., H. Hetherington, and J. Ord. 1941. A study of tuberculosis among students of nursing. J.A.M.A. 117:461-473.
20. Falk, A., and G. F. Fuchs. 1978. Prophylaxis with isoniazid in inactive tuberculosis: a Veterans Administration Cooperative Study XII. Chest 73:44-48.
21. Selwyn, P. A., D. Hartel, V. A. Lewis, E. E. Schoenbaum, S. H. Vermund, R. S. Klein, A. T. Walker, and G. H. Friedland. 1989. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N. Engl. J. Med. 320:545-550.
22. Riley, L. 1996. Phagocytosis of M. tuberculosis. In W. Rom and S. Garay, editors. Tuberculosis. Little, Brown, Boston, MA. 281-289.
23. Steinman, R. M., M. Witmer-Pack, and K. Inaba. 1993. Dendritic cells: antigen presentation, accessory function and clinical relevance. Adv. Exp. Med. Biol. 329:1-9.
24. Schlesinger, L. S. 1996. Entry of Mycobacterium tuberculosis into mononuclear phagocytes. Curr. Top. Microbiol. Imnumol. 215:71-96.
25. Schlesinger, L. S. 1996. Role of mononuclear phagocytes in M. tuberculosis pathogenesis. J. Investig. Med. 44:312-323.
26. Schlesinger, L., C. Bellinger-Kawahar, N. Payne, and M. Horwitz. 1990. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J. Immunol. 144:477-495.
27. Schlesinger, L. S. 1993. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 150:2920-2930.
28. Schlesinger, L., S. Hull, and T. Kaufman. 1994. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J. Immunol. 152:4070-4079.
29. Czop, J., and J. Kay. 1991. Isolation and characterization of β-glucan receptors on human mononuclear phagocytes. J. Exp. Med. 173:1511-1520.
30. Barnes, P., R. L. Modlin, and J. J. Ellner. 1994. T-cell responses and cytokines. In B. Bloom, editor. Tuberculosis: Pathogenesis, Protection, and Control. ASM Press, Washington, DC. 417-435.
31. Wright, S., P. Detmers, M. Jong, and B. Meyer. 1986. Interferon-γ depresses binding of ligand by C3b and C3bi receptors on cultured human monocytes, an effect reversed by fibronectin. J. Exp. Med. 163:1245-1259.
32. Downing, J., R. Pasula, J. Wright, H. Twigg, and W. Martin. 1995. Surfactant protein A promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 92:4848-4852.
33. Gaynor, C., F. McCormack, D. Voelker, S. McGowan, and L. Schlesinger. 1995. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J. Immunol. 155:5343-5351.
34. Hoheisel, G., L. Zheng, H. Teschler, I. Striz, and U. Costabel. 1995. Increased soluble CD14 levels in BAL fluid in pulmonary tuberculosis. Chest 108:1614-1616.
35. Zhang, Y., M. Doerfler, T. Lee, B. Guillemin, and R. WN. 1993. Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components. J. Clin. Invest. 91:2076-2083.
36. Zimmerli, S., S. Edwards, and J. Ernst. 1996. Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. Am. J. Respir. Cell Mol. Biol. 15:760-770.
37. Allen, J., E. Brieger, and R. Rees. 1965. Electron microscopy of the host-parasite relation in murine leprosy. J. Pathol. Bacteriol. 89:301-306.
38. Carrol, M., P. Jackett, V. Aber, and D. Lowrie. 1979. Phagolysosome formation, cyclic adenosine 3′:5′-monophosphate and the fate of Salmonella typhimurium within mouse peritoneal macrophages. J. Gen. Microbiol. 110:421-429.
39. Mor, N. 1983. Intracellular location of Mycobacterium leprae in macrophages of normal and immune-deficient mice and effect of rifampin. Infect. Immun. 42:802-811.
40. Gordon, A. H., P. D'Arcy Hart, and M. R. Young. 1980. Ammonia inhibits phagosome-lysosome fusion in macrophages. Nature 286:79-80.
41. Goren, M. B., O. Brokl, and W. B. Schaefer. 1974. Lipids of putative relevance to virulence in Mycobacterium tuberculosis: phthiocerol dimycocerosate and the attenuation indicator lipid. Infect. Immun. 9:150-158.
42. Goren, M. B., P. D'Arcy Hart, M. R. Young, and J. A. Armstrong. 1976. Prevention of phagosome-lysosome fusion in cultured macrophages by sulfatides of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 73:2510-2514.
43. Jackett, P. S., V. R. Aber, and D. B. Lowrie. 1978. Virulence and resistance to superoxide, low pH and hydrogen peroxide among strains of Mycobacterium tuberculosis. J. Gen. Microbiol. 104:37-45.
44. Sturgill-Koszycki, S., P. H. Schlesinger, P. Chakraborty, P. L. Haddix, H. L. Collins, A. K. Fok, R. D. Allen, S. L. Gluck, J. Heuser, and D. G. Russell. 1994. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase (see comments). Science 263:678-681. (Erratum appears in Science 1994;263:1359).
45. McDonough, K. A., Y. Kress, and B. R. Bloom. 1993. Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages. Infect. Immun. 61:2763-2773. (Erratum appears in Infect. Immun. 1993;61:4021-4024).
46. Moreira, A. L., J. Wang, L. Tsenova-Berkova, W. Hellmann, V. H. Freedman, and G. Kaplan. 1997. Sequestration of Mycobacterium tuberculosis in tight vacuoles in vivo in lung macrophages of mice infected by the respiratory route. Infect. Immun. 65:305-308.
47. Via, L. E., D. Deretic, R. J. Ulmer, N. S. Hibler, L. A. Huber, and V. Deretic. 1997. Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7. J. Biol. Chem. 272:13326-13331.